Table 1 Summary of demographic data and other baseline characteristics in the safety population

From: Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

 

Treatment group 1: thermostable single-vial presentation of ID93 + GLA-SE

Treatment group 2: non-thermostable two-vial presentation of ID93 + GLA-SE

Age (yrs)

  Mean

28.3

27.3

  Std deviation

9.07

8.82

  Std error

1.89

1.76

  Median

23.0

23.0

  Interquartile range (IQR)

21.0–37.5

20.0–32.0

Gender

  Female

18 (78.3%)

18 (72.0%)

  Male

5 (21.7%)

7 (28.0%)

Race

  White

20 (87.0%)

23 (92.0%)

  Asian

2 (8.7%)

0

  Black or African American

0

1 (4.0%)

  Native Hawaiian or other Pacific Islander

0

0

  American Indian or Alaskan native

0

0

  Mixed race

1 (4.3%)

1 (4.0%)

Other

0

0

BMI (kg m−2)

Mean

24.1

24.1

  Std deviation

3.88

3.03

  Std error

0.81

0.61

  Median

24.0

23.8

  IQR

20.7–26.3

21.9–25.6